Search Results - "Behr, T. M"

Refine Results
  1. 1

    Combination of ‘idiopathic’ REM sleep behaviour disorder and olfactory dysfunction as possible indicator for α-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT by Stiasny-Kolster, K., Doerr, Y., Möller, J. C., Höffken, H., Behr, T. M., Oertel, W. H., Mayer, G.

    Published in Brain (London, England : 1878) (01-01-2005)
    “…REM sleep behaviour disorder (RBD) and olfactory dysfunction are common and very early features of α-synucleinopathies, in particular Parkinson's disease. To…”
    Get full text
    Journal Article
  2. 2

    High-resolution SPECT using multipinhole collimation by Schramm, N.U., Ebel, G., Engeland, U., Schurrat, T., Behe, M., Behr, T.M.

    Published in IEEE transactions on nuclear science (01-06-2003)
    “…The authors present a novel SPECT imaging technique for small animal research based on multipinhole collimation. This new method is an extension of…”
    Get full text
    Journal Article
  3. 3

    Quantitative [123I]FP-CIT pinhole SPECT imaging predicts striatal dopamine levels, but not number of nigral neurons in different mouse models of Parkinson's disease by Alvarez-Fischer, D., Blessmann, G., Trosowski, C., Béhé, M., Schurrat, T., Hartmann, A., Behr, T.M., Oertel, W.H., Höglinger, G.U., Höffken, H.

    Published in NeuroImage (Orlando, Fla.) (15-10-2007)
    “…Single photon emission computed tomography (SPECT) using [123I]FP-CIT as radioligand for the dopamine transporter has become a widely used tool to monitor the…”
    Get full text
    Journal Article
  4. 4

    Reducing the renal uptake of radiolabeled antibody fragments and peptides for diagnosis and therapy: present status, future prospects and limitations by Behr, T M, Goldenberg, D M, Becker, W

    Published in European journal of nuclear medicine (01-02-1998)
    “…Elevated renal uptake and prolonged retention of radiolabeled antibody fragments and peptides is a problem in the therapeutic application of such agents. Over…”
    Get full text
    Journal Article
  5. 5

    Radiolabeled Peptides for Targeting Cholecystokinin-B/Gastrin Receptor-Expressing Tumors by Behr, Thomas M, Jenner, Niels, Behe, Martin, Angerstein, Christa, Gratz, Stefan, Raue, Friedhelm, Becker, Wolfgang

    Published in The Journal of nuclear medicine (1978) (01-06-1999)
    “…The high sensitivity of pentagastrin stimulation in detecting primary or metastatic medullary thyroid cancer (MTC) suggests widespread expression of the…”
    Get full text
    Journal Article
  6. 6

    Incidental Non-Secreting Adrenal Masses in Cancer Patients: Intra-Individual Comparison of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography with Computed Tomography and Shift Magnetic Resonance Imaging by Gratz, S, Kemke, B, Kaiser, W, Heinis, J, Behr, TM, Höffken, H

    Published in Journal of international medical research (01-03-2010)
    “…The ability of integrated 18F-fluoro-deoxyglucose positron emission tomography and computed tomography (FDG PET/CT) to distinguish between benign and malignant…”
    Get full text
    Journal Article
  7. 7

    Development and clinical application of peptide-based radiopharmaceuticals by Gotthardt, M, Boermann, O C, Behr, T M, Béhé, M P, Oyen, W J G

    Published in Current pharmaceutical design (01-09-2004)
    “…Peptide-based radiopharmaceuticals have been introduced into clinical work more than a decade ago. The first and most successful imaging agent to date is the…”
    Get more information
    Journal Article
  8. 8

    Therapeutic advantages of Auger electron- over beta-emitting radiometals or radioiodine when conjugated to internalizing antibodies by Behr, T M, Béhé, M, Löhr, M, Sgouros, G, Angerstein, C, Wehrmann, E, Nebendahl, K, Becker, W

    Published in European journal of nuclear medicine (01-07-2000)
    “…Recent studies suggest a higher anti-tumour efficacy of internalizing monoclonal antibodies (MAbs) when labelled with Auger electron emitters, as compared with…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Targeting of cholecystokinin-B/gastrin receptors in vivo: preclinical and initial clinical evaluation of the diagnostic and therapeutic potential of radiolabelled gastrin by Behr, T M, Jenner, N, Radetzky, S, Béhe, M, Gratz, S, Yücekent, S, Raue, F, Becker, W

    Published in European journal of nuclear medicine (01-04-1998)
    “…The outstanding sensitivity of pentagastrin in detecting the presence of primary, recurrent or metastatic medullary thyroid cancer (MTC) suggests widespread…”
    Get full text
    Journal Article
  11. 11

    LeukoScan for Imaging Infection in Different Clinical Settings: A Retrospective Evaluation and Extended Review of the Literature by GRATZ, S, SCHIPPER, M L, DÖRNER, J, HÖFFKEN, H, BECKER, W, KAISER, J W, BÉHÉ, M, BEHR, T M

    Published in Clinical nuclear medicine (01-04-2003)
    “…PURPOSE The aim of the current study was to determine the overall diagnostic accuracy of Tc-99m–labeled antigranulocyte monoclonal antibody Fab’ fragments…”
    Get full text
    Journal Article
  12. 12

    99mTc-Labeling and in Vitro and in Vivo Evaluation of HYNIC- and (Nα-His)Acetic Acid-Modified [d-Glu1]-Minigastrin by von Guggenberg, E, Behe, M, Behr, T. M, Saurer, M, Seppi, T, Decristoforo, C

    Published in Bioconjugate chemistry (01-07-2004)
    “…Gastrin/CCK-2 receptors are overexpressed in a number of tumors such as medullary thyroid cancer (MTC) and small cell lung cancer (SCLC). Recently…”
    Get full text
    Journal Article
  13. 13

    Correlation between radiation dose, synovial thickness, and efficacy of radiosynoviorthesis by Gratz, S, Göbel, D, Behr, T M, Herrmann, A, Becker, W

    Published in Journal of rheumatology (01-06-1999)
    “…To correlate the therapeutic efficacy of radiosynoviorthesis (RSO) to radiation doses achieved. In 20 patients with known rheumatoid arthritis,…”
    Get more information
    Journal Article
  14. 14

    Phase I/II Clinical Radioimmunotherapy with an Iodine-131 -Labeled Anti-Carcinoembryonic Antigen Murine Monoclonal Antibody IgG by Behr, Thomas M, Sharkey, Robert M, Juweid, Malik E, Dunn, Robert M, Vagg, Rae C, Ying, Zhiliang, Zhang, Cun-H, Swayne, Lawrence C, Vardi, Yehuda, Siegel, Jeffry A, Goldenberg, David M

    Published in The Journal of nuclear medicine (1978) (01-06-1997)
    “…The aim of this study was to determine, in a Phase I/II clinical trial, the pharmacokinetics, dosimetry and toxicity, as well as antitumor activity, of the…”
    Get full text
    Journal Article
  15. 15

    Reduction of the renal uptake of radiolabeled monoclonal antibody fragments by cationic amino acids and their derivatives by BEHR, T. M, SHARKEY, R. M, JUWEID, M. E, BLUMENTHAL, R. D, DUNN, R. M, GRIFFITHS, G. L, BAIR, H.-J, WOLF, F. G, BECKER, W. S, GOLDENBERG, D. M

    Published in Cancer research (Chicago, Ill.) (01-09-1995)
    “…The renal uptake of radiolabeled antibody fragments and peptides is a problem in radioimmunodetection and radioimmunotherapy, especially with intracellular…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Rapid blood clearance of mouse IgG2a and human IgG1 in many nude and nu/+ mouse strains is due to low IgG2a serum concentrations by REDDY, N, GAIK LIN ONG, BEHR, T. M, SHARKEY, R. M, GOLDENBERG, D. M, MATTES, M. J

    Published in Cancer Immunology, Immunotherapy (01-03-1998)
    “…We reported previously that the blood clearance of injected mouse IgG2a was extremely rapid in many strains of nude and nu/+ mice. In an attempt to determine…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Reduction of Renal Uptake of Monoclonal Antibody Fragments by Amino Acid Infusion by Behr, Thomas M, Becker, Wolfgang S, Sharkey, Robert M, Juweid, Malik E, Dunn, Robert M, Bair, Hans-J, Wolf, Friedrich G, Goldenberg, David M

    Published in The Journal of nuclear medicine (1978) (01-05-1996)
    “…The renal uptake of radiolabeled antibody fragments and peptides presents a problem in radioimmunodetection and therapy, compromising lesion sensitivity,…”
    Get full text
    Journal Article
  20. 20

    What is the best pre-therapeutic dosimetry for successful radioiodine therapy of multifocal autonomy? by Gotthardt, M, Rubner, C, Bauhofer, A, Berce, F, Oyen, W J G, Goecke, J, Pfestroff, A, Schlieck, A, Corstens, F H, Béhé, M, Behr, T M

    Published in Nuclear medicine (01-01-2006)
    “…Dose calculation for radioiodine therapy (RIT) of multifocal autonomies (MFA) is a problem as therapeutic outcome may be worse than in other kinds of…”
    Get more information
    Journal Article